Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

QUIA PHARMA

0,005

 

SEK

 

-2,13 %

Mindre end 1K følgere

QUIA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus

QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.

Læs mere
Markedsværdi
9,77 mio. SEK
Aktieomsætning
67,39 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
26.6
2025

Generalforsamling '25

28.8
2025

Delårsrapport Q2'25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelse21.2.2024, 17.40

CORRECTION: QuiaPEG has submitted a formal application to Nasdaq in relation to the company’s acquisition of intellectual property rights from Rosemonkey Ltd.

QUIA PHARMA
Pressemeddelelse20.2.2024, 07.00

QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.

QUIA PHARMA
Pressemeddelelse15.2.2024, 13.25

QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement

QUIA PHARMA

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse8.11.2023, 07.22

QuiaPEG enters conditional agreement on a reverse takeover and financing to enable continued business development of existing operations

QUIA PHARMA
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.